Author:
Kyle Edward,Neckers Len,Takimoto Chris,Curt Gregory,Bergan Raymond
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Subject
Pharmacology,Molecular Medicine
Reference35 articles.
1. Cancer statistics, 1996
2. Dawson N. A. Kobayashi K. Vogelzang N. J. (1994) Recent therapeutic advances in “hormone-refractory” metastatic prostate cancer: flutamide withdrawal, estramustine plus vinblastine, estramustine plus etoposide, and suramin. in Prostate Cancer, eds Dawson N. A. Vogelzang N. J. (Wiley, New York), pp 235–260.
3. Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.;Cher;Prostate,1995
4. Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action.;Rowley;Cancer Res.,1995
5. Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cells
Cited by
162 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献